Glucoamylase variants and polynucleotides encoding same

US9353362B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9353362-B2
Application numberUS-201214351469-A
CountryUS
Kind codeB2
Filing dateOct 11, 2012
Priority dateOct 11, 2011
Publication dateMay 31, 2016
Grant dateMay 31, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to glucoamylase variants having improved thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

First claim

Opening claim text (preview).

The invention claimed is: 1. A glucoamylase variant having improved thermostability, comprising a substitution at a positon corresponding to position 65 of the polypeptide of SEQ ID NO: 3,wherein the variant has glucoamylase activity and wherein the variant has at least 90% sequence identity to the polypeptide of SEQ ID NO: 3. 2. The variant of claims 1 , wherein the variant has at least at 95% sequence identity to SEQ ID NO: 3. 3. The variant of claim 1 , wherein the variant has at least 97% sequence identity to the polypeptide of SEQ ID NO: 3. 4. The variant of claim 1 , wherein the variant has at least 98% sequence identity to SEQ ID NO: 3. 5. The variant of claim 1 , wherein the variant has at least 99% sequence identity to SEQ ID NO: 3. 6. The variant of claim 1 , wherein the variant has a number of substitutions in the amount of 1-20. 7. The variant of claim 1 , further comprising one or more substitution or deletion in at least one position selected from position 327, 501, and 504 of SEQ ID NO: 3. 8. The variant of claim 1 , wherein the variant further comprises or consists of one or more substitutions selected from the group consisting of T65A, Q327F, E501V, Y504T, and Y504*. 9. The variant of claim 1 , wherein the variant comprises at least one of the following alterations or combinations of alterations: T65A; or T65A +Q327F; or T65A +E501V; or T65A +Y504T; or T65A +Y504*; or T65A +Q327F +E501V; or T65A +Q327F +Y504T; or T65A +E501V +Y504T; or T65A +Q327F +Y504*; or T65A +E501V +Y504*; or T65A +Q327F +E501V +Y504T; or T65A +Q327F +E501V +Y504*. 10. The variant of claim 1 , wherein the variant comprises one of the following combinations of substitutions: T65A +K161S; T65A +Q405T; T65A +Q327W; T65A +Q327F; T65A +Q327Y; P11F +T65A +Q327F; R1 K +D3W +K5Q +G7V +N8S +T1OK +P11S +T65A +Q327F; P2N +P4S +P11F +T65A +Q327F; P11F +D26C +K33C +T65A +Q327F; P2N +P4S +P11F +T65A +Q327W +E501V +Y504T; R1E +D3N +P4G +G6R +G7A +N8A +T10D+P11D +T65A +Q327F; P11F +T65A +Q327W; P2N +P4S +P11F +T65A +Q327F +E501V +Y504T; P11F +T65A +Q327W +E501V +Y504T; T65A +Q327F +E501V +Y504T; T65A +S105P +Q327W; T65A +S105P +Q327F; T65A +Q327W +S364P; T65A +Q327F +S364P; T65A +S103N +Q327F; P2N +P4S +P11F +K34Y +T65A +Q327F; P2N +P4S +P11F +T65A +Q327F +D445N +V447S; P2N +P4S +P11F +T65A +I172V +Q327F; P2N +P4S +P11F +T65A +Q327F +N502*; P2N +P4S +P11F +T65A +Q327F +N502T +P563S +K571E; P2N +P4S +P11F +R31S +K33V +T65A +Q327F +N564D +K571S; P2N +P4S +P11F +T65A +Q327F +S377T; P2N +P4S +P11 F +T65A +V325T+Q327W; P2N +P4S +P11 F +T65A +Q327F +D445N +V447S +E501V +Y504T; P2N +P4S +P11F +T65A +1172V +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +S377T +E501V +Y504T; P2N +P4S +P11F +D26N +K34Y +T65A +Q327F; P2N +P4S +P11F +T65A +Q327F +1375A +E501V +Y504T; P2N +P4S +P11F +T65A +K218A +K221D +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +S103N +Q327F +E501V +Y504T; P2N +P4S +T1 OD +T65A +Q327F +E501V +Y504T; P2N +P4S +F12Y +T65A +Q327F +E501V +Y504T; K5A +P11F +T65A +Q327F +E501V +Y504T; P2N +P4S +T1OE +E18N +T65A +Q327F +E501V +Y504T; P2N +T1OE +E18N +T65A +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +E501V +Y504T +T568N; P2N +P4S +P11 F +T65A +Q327F +E501V +Y504T +K524T +G526A; P2N +P4S +P11 F +K34Y +T65A +Q327F +D445N +V447S +E501V +Y504T; P2N +P4S +P11F +R31S +K33V +T65A +Q327F +D445N +V447S +E501V +Y504T; P2N +P4S +P11F +D26N +K34Y +T65A +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +F80* +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +K112S +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +E501V +Y504T +T516P +K524T +G526A; P2N +P4S +P11F +T65A +Q327F +E501V +N502T +Y504*; P2N +P4S +P11F +T65A +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +S103N +Q327F +E501V +Y504T; K5A +P11F +T65A +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +E501V +Y504T +T516P +K524T +G526A; P2N +P4S +P11F +T65A +V79A +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +V79G +Q327F +E501V +Y504T; P2N +P4S +P11 F +T65A +V791 +Q327F +E501V +Y504T; P2N +P4S +P11 F +T65A +V79L +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +V79S +Q327F +E501V +Y504T; P2N +P4S +P11 F +T65A +L72V +Q327F +E501V +Y504T; P2N +P4S +P11 F +T65A +E74N +V79K +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +G220N +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Y245N +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q253N +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +D279N +Q327F +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +S359N +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +D370N +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +V460S +E501V +Y504T; P2N +P4S +P11 F +T65A +Q327F +V460T +P468T +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +T463N +E501V +Y504T; P2N +P4S +P11F +T65A +Q327F +S465N +E501V +Y504T; or P2N +P4S +P11F +T65A +Q327F +T477N +E501V +Y504T. 11. The variant of claim 1 , which has an improved property relative to a parent, wherein the improved property is reduced sensitivity to protease degradation. 12. The variant of claim 1 , which has an improved property relative to a parent, wherein the improved property is improved thermostability. 13. A variant glucoamylase catalytic domain comprising a substitution at a position corresponding to position 65 of the polypeptide of SEQ ID NO: 3, wherein the variant has glucoamylase activity. 14. A composition comprising the polypeptide of claim 1 . 15. A composition according to claim 14 , comprising an alpha-amylase. 16. A process of producing a fermentation product from starch-containing material comprising the steps of: (a) liquefying starch-containing material in the presence of an alpha amylase; (b) saccharifying the liquefied material; and (c) fermenting with a fermenting organism; wherein step (a) and/or step (b) is carried out using at least a glucoamylase of claim 1 . 17. A process of producing a fermentation product from starch-containing material, comprising the steps of: (a) saccharifying starch-containing material at a temperature below the initial gelatinization temperature of said starch-containing material; and (b) fermenting with a fermenting organism, wherein step (a) is carried out using at least a glucoamylase of claim 1 .

Assignees

Inventors

Classifications

  • Biofuels, e.g. bio-diesel · CPC title

  • produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose · CPC title

  • C12N9/2428Primary

    Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase · CPC title

  • Preparation of compounds having a 4-thia-1-azabicyclo [3.2.0] heptane ring system, e.g. penicillin · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9353362B2 cover?
The present invention relates to glucoamylase variants having improved thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Who is the assignee on this patent?
Novozymes As
What technology area does this patent fall under?
Primary CPC classification C12N9/2428. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).